United States · FDA National Drug Code directory
Tolterodine Tartrate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-607_e16012ae-5972-470b-8a22-b0626a029e95
- Product NDC
- 31722-607
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Tolterodine Tartrate
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170602
- Source listing expiry
- 20261231
Source-listed ingredients
- TOLTERODINE TARTRATE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (31722-607-05) · 31722-607-05
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (31722-607-30) · 31722-607-30
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (31722-607-90) · 31722-607-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →